Risk factors for visual field damage progression in normal-tension glaucoma eyes

被引:69
作者
Daugeliene, L [1 ]
Yamamoto, T [1 ]
Kitazawa, Y [1 ]
机构
[1] Gifu Univ, Sch Med, Dept Ophthalmol, Gifu 5008705, Japan
关键词
D O I
10.1007/s004170050203
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: This study was carried out to evaluate intraocular or systemic factors associated with the visual field damage progression in eyes with normal-tension glaucoma (NTG). Patients and methods: Forty-seven NTG eyes with a minimum follow-up of 5 years were enrolled into the retrospective study. A stepwise regression analysis was performed to correlate the visual field damage progression, expressed as the mean deviation (MD) change per year, with several independent clinical factors including age, history of disc hemorrhage, initial MD, mean intraocular pressure (IOP), peak IOP, diurnal fluctuation of IOP, presence of a beta zone of peripapillary atrophy, and use of Ca2+-channel blockers. Results: Statistical analysis revealed that non-use of Ca2+-channel blockers (P=0.01), peripapillary atrophy (P=0.03) and disc hemorrhage (P=0.04) were associated with visual loss progression. Conclusions: Risk factors unrelated to IOP were suggested to be associated with progression of visual field loss. Systemic use of Ca2+-channel blockers has a favorable effect on visual field prognosis in NTG eyes.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 17 条
[1]  
ABEDIN S, 1982, OPHTHALMOLOGY, V89, P1
[2]   OPTIC DISK HEMORRHAGES PRECEDE RETINAL NERVE-FIBER LAYER DEFECTS IN OCULAR HYPERTENSION [J].
AIRAKSINEN, PJ ;
MUSTONEN, E ;
ALANKO, HI .
ACTA OPHTHALMOLOGICA, 1981, 59 (05) :627-641
[3]  
ARAIE M, 1994, OPHTHALMOLOGY, V101, P1440
[4]  
BOISSONNOT M, 1992, J FR OPHTALMOL, V15, P645
[5]   RESPONSE OF BLOOD-FLOW TO WARM AND COLD IN NORMAL AND LOW-TENSION GLAUCOMA PATIENTS [J].
DRANCE, SM ;
DOUGLAS, GR ;
WIJSMAN, K ;
SCHULZER, M ;
BRITTON, RJ .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1988, 105 (01) :35-39
[6]  
Flammer J., 1987, DOC OPHTHALMOL PROC, V49, P397
[7]  
JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P919
[8]  
KITAZAWA Y, 1986, OPHTHALMOLOGY, V93, P853
[9]   THE EFFECT OF CA-2+-ANTAGONIST ON VISUAL-FIELD IN LOW-TENSION GLAUCOMA [J].
KITAZAWA, Y ;
SHIRAI, H ;
GO, FJ .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1989, 227 (05) :408-412
[10]  
Liu S, 1996, J GLAUCOMA, V5, P187